Depending on availability, mRNA vaccines, such as those developed by Pfizer Inc and Moderna Inc can be used as subsequent doses after initial doses of AstraZeneca's vectored vaccine and vice versa, the global health body said.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3F7U6VO
0 Comments